(Q41733617)

8 October 2017

Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice (English)

1 reference

8 October 2017

1 reference

Jiansen Chen

1

1 reference

8 October 2017

Neng Li

series ordinal

2

1 reference

8 October 2017

Feifei She

series ordinal

3

1 reference

8 October 2017

language of work or name

English

0 references

publication date

16 September 2014

1 reference

8 October 2017

1 reference

8 October 2017

32

1 reference

8 October 2017

46

1 reference

8 October 2017

6054-6060

1 reference

Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Inflammation, immunity, and vaccine development for Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Biological delivery approaches for gene therapy: strategies to potentiate efficacy and enhance specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Molecular delivery of plasmids for genetic vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

The Bacterial Ghost platform system: production and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts as carrier and targeting systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Effective gene transfer to melanoma cells using bacterial ghosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

The current status of Helicobacter pylori vaccines: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts are an efficient delivery system for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

Immobilization of plasmid DNA in bacterial ghosts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.09.014

10.1016/J.VACCINE.2014.09.014

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference